FDA Clearance Tracker · P190015-S016
TREO® Abdominal Stent-Graft System
Last checked: Nov 20, 2026Latest source record: May 22, 2024 (this decision)Source: openFDAMethods & limitations
Decided
May 22, 2024
Approved
Time to decision
65 days
Received Mar 18, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P190015-S016
- Device name
- TREO® Abdominal Stent-Graft System
- Applicant
- Bolton Medical, Inc.
- Applicant location
- Sunrise, FL
- Received
- Mar 18, 2024
- Decided
- May 22, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P190015
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
approval for a manufacturing site Terumo Aortic Glasgow located at Newmains Ave, Inchinnan, Glasgow PA4 9RR, United Kingdom for manufacture of the Delivery System subassembly, loading of the Stent-Graft subassembly onto the Delivery System, and non-sterile packaging of the loaded Delivery System subassemblies of the Bifurcate and Cuff components of the TREO® Abdominal Stent-Graft System
Source documents
Other decisions for Bolton Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- RelayPro Thoracic Stent-Graft SystemPMA supplement
P200045-S002 · Decided Mar 7, 2023 · 295 days after receipt · Panel Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
P200045 · Decided Aug 5, 2021 · 258 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
P190015 · Decided May 4, 2020 · 336 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.